Quantum Biopharma (QNTM) Free Cash Flow (2019 - 2026)

Quantum Biopharma has disclosed Free Cash Flow across 7 years of filings, most recently posting -$1.7 million for Q1 2026.

• Free Cash Flow for Q1 2026 came in at -$1.7 million, up 60.84% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.6 million (up 38.4% YoY), and the FY2025 annual result was -$8.2 million, down 19.79% from the prior year.
• Free Cash Flow came in at -$1.7 million for Q1 2026 at Quantum Biopharma, down from -$305598.0 in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $9.4 million in Q2 2022 to a low of -$50.6 million in Q4 2022.
• The 4-year median for Free Cash Flow is -$1.7 million (2026), against an average of -$3.5 million.
• Across the five-year window, Free Cash Flow surged 65.96% in 2022 and sank 221.38% in 2025, its largest moves.
• Quantum Biopharma's Free Cash Flow stood at -$50.6 million in 2022, then surged by 98.35% to -$835762.0 in 2024, then surged by 63.43% to -$305598.0 in 2025, then tumbled by 446.06% to -$1.7 million in 2026.
• The last three Free Cash Flow figures came in at -$1.7 million (Q1 2026), -$305598.0 (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.